Optellum Virtual Nodule Clinic vs Subtle Medical

Optellum's reimbursement page lists CPT Category III codes 0721T and +0722T and a Medicare hospital outpatient APC 1508 rate of $650.50 (currency not stated) for 2026, a national average before deductibles. The vendor says SimonMed built the lung cancer prediction score into its workflow, which makes outpatient imaging groups running a nodule service the audience.

Subtle Medical sells vendor-neutral software to imaging departments. SubtleHD covers MR, PET and CT, with the PET version (K254013) decided May 14, 2026. A Series C announced June 2, 2026, led by Morgan Stanley Expansion Capital, came with Ohad Arazi named CEO. An outpatient center whose bottleneck is MR scanner time gets little from Optellum, which scores lung nodules on CT, so Optellum trails there. Departments after the up to 80% faster MRI sequences the vendor claims are Subtle's buyers.